2[1]White WB, Morganroth. Usefulness of ambulatory monitoring of BP assessing antihypertensive therapy [J]. Am J Cardiol, 1989,63: 394.
3[3]Goodriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists [J]. Neng I J Med, 1996, 334: 1649-1654.
4[4]Oliverio MI, Coffman T M. Angiotensin- Ⅱ receptors for antihypertensive therapy [J]. Clin Cardiol 1997, 20: 3-6.
5Douglas PS,Reichek N,Plappert T,et al. Comparison of echocardiographic methods for assessment of left ventricular shortering and wall stress[J].J Am Cardiol, 1987,9(4):945-951.
6Dzau VJ,Colucci WS, Hollenberg NK,et al. Relation of the rennin angiotensin aldosterone system to clinical state in congestive heart failure[J]. Circulation, 1981,63(3) :645-651.
7Kang PM, Landau AJ, Eberhardt RT,et al. Angiotensin Ⅱ receptor antagonists:a new approach to blockade of the rennin-angiotensin system [J]. Am Heart J,1994,127(5):1388-1401.
8Zabalgoitia M. Left ventricular mass and function in primary hypertention[J]. Am J Hypertens, 1996,9(8) :55S-59S.
9LINZ W, SCHAPER J, WIEMER G, et al. Ramipril prevents left ventricular hepertrophy with myocardial fibrosis without blood pressure reductions A one year study in rats[J]. Br J Pharmacol, 1992,107(4) : 970-975.
10VERDECHIAP, PORCELLATI C, REBOLDI G, et al. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension[J].Circulation,2001,104(17),2039-2044.
